Literature DB >> 29382228

Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions.

Philippe Codron1,2,3, Julien Cassereau1,2, Patrick Vourc'h4,5, Charlotte Veyrat-Durebex2, Hélène Blasco2,4,5, Selma Kane2, Vincent Procaccio2, Franck Letournel3, Christophe Verny2, Guy Lenears2, Pascal Reynier2, Arnaud Chevrollier2.   

Abstract

OBJECTIVE: Sporadic amyotrophic lateral sclerosis (sALS) is a fatal neurodegenerative disorder affecting upper and lower motor neurons. In view of the heterogeneous presentation of the disease, one of the current challenges is to identify diagnostic and prognostic markers in order to diagnose sALS at early stage and to stratify patients in trials. In this study, we sought to identify cytological hallmarks of sALS in patient-derived fibroblasts with the aim of finding new clinical-related markers of the disease.
METHODS: Primary fibroblasts were prospectively collected from patients affected with classical, rapid, and slow forms of sALS. TDP-43 localization, cytoskeleton distribution, mitochondrial network architecture, and stress granules formation were analyzed using 3D fluorescence microscopy and new super-resolution imaging. Intracellular reactive oxygen species (ROS) production was assessed using live imaging techniques.
RESULTS: Six sALS patients (two classical, two rapid, and two slow) and four age-matched controls were included. No difference in fibroblasts cell growth, morphology, and distribution was noticed. The analysis of TDP-43 did not reveal any mislocalization nor aggregation of the protein. The cytoskeleton was harmoniously distributed among the cells, without any inclusion noticed, and no difference was observed regarding the mitochondrial network architecture. Basal ROS production and response to induced stress were similar among patient and control fibroblasts.
CONCLUSIONS: ALS cytological lesions are absent in patient-derived fibroblasts and thus cannot contribute as diagnostic nor prognostic markers of the disease.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; TDP-43; cytoskeleton; mitochondria; oxidative stress; primary skin fibroblasts; stress granules

Mesh:

Substances:

Year:  2018        PMID: 29382228     DOI: 10.1080/21678421.2018.1431787

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  8 in total

Review 1.  TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.

Authors:  Ju Gao; Luwen Wang; Tingxiang Yan; George Perry; Xinglong Wang
Journal:  Mol Cell Neurosci       Date:  2019-08-21       Impact factor: 4.314

2.  TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics.

Authors:  Stephani A Davis; Sheed Itaman; Christopher M Khalid-Janney; Justin A Sherard; James A Dowell; Nigel J Cairns; Michael A Gitcho
Journal:  Neurosci Lett       Date:  2018-04-30       Impact factor: 3.046

3.  Next-Generation Sequencing Identifies Novel PMPCA Variants in Patients with Late-Onset Dominant Optic Atrophy.

Authors:  Majida Charif; Arnaud Chevrollier; Naïg Gueguen; Selma Kane; Céline Bris; David Goudenège; Valerie Desquiret-Dumas; Isabelle Meunier; Fanny Mochel; Luc Jeanjean; Fanny Varenne; Vincent Procaccio; Pascal Reynier; Dominique Bonneau; Patrizia Amati-Bonneau; Guy Lenaers
Journal:  Genes (Basel)       Date:  2022-07-05       Impact factor: 4.141

Review 4.  Stress Granules and Neurodegenerative Disorders: A Scoping Review.

Authors:  Mohammad Reza Asadi; Marziyeh Sadat Moslehian; Hani Sabaie; Abbas Jalaiei; Soudeh Ghafouri-Fard; Mohammad Taheri; Maryam Rezazadeh
Journal:  Front Aging Neurosci       Date:  2021-06-23       Impact factor: 5.750

5.  Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients.

Authors:  Qiuying Chen; Csaba Konrad; Davinder Sandhu; Dipa Roychoudhury; Benjamin I Schwartz; Roger R Cheng; Kirsten Bredvik; Hibiki Kawamata; Elizabeth L Calder; Lorenz Studer; Steven M Fischer; Giovanni Manfredi; Steven S Gross
Journal:  Neurobiol Dis       Date:  2020-08-01       Impact factor: 5.996

6.  Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.

Authors:  Merina Varghese; Wei Zhao; Kyle J Trageser; Giulio M Pasinetti
Journal:  Biomolecules       Date:  2020-05-13

7.  Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons.

Authors:  Silvia Pozzi; Philippe Codron; Geneviève Soucy; Laurence Renaud; Pierre Junior Cordeau; Kallol Dutta; Christine Bareil; Jean-Pierre Julien
Journal:  JCI Insight       Date:  2020-11-05

8.  TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients.

Authors:  Miguel A Rubio; Mireia Herrando-Grabulosa; Roser Velasco; Israel Blasco; Monica Povedano; Xavier Navarro
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.